Prothena Corp Public (PRTA) Receivables - Net (2014 - 2023)
Prothena Corp Public (PRTA) recorded quarterly Receivables - Net of $5.2 million in Q4 2023, little changed quarter-over-quarter from $5.2 million in Q3 2023.
Prothena Corp Public (PRTA) Receivables - Net (2014 - 2023) Analysis & Trends
Prothena Corp Public's Receivables - Net history runs 9 years deep, the most recent figure standing at $5.2 million for Q4 2023.
- In Q4 2023, Receivables - Net changed N/A year-over-year to $5.2 million; the TTM figure through Dec 2023 stood at $5.2 million (changed N/A YoY), while the FY2023 annual figure was $5.2 million, changed N/A from the prior year.
- Receivables - Net was $5.2 million for Q4 2023 at Prothena Corp Public, roughly flat from $5.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $5.2 million in Q3 2023 to a low of $1000.0 in Q1 2021.
- Historically, Receivables - Net has averaged $869923.1 across 4 years, with a median of $56000.0 in 2020.
- Biggest YoY gain for Receivables - Net was 3300.0% in 2019; the steepest drop was 99.99% in 2019.
- A 4-year view of Receivables - Net shows it stood at $68000.0 in 2019, then tumbled by 77.94% to $15000.0 in 2020, then jumped by 426.67% to $79000.0 in 2021, then surged by 6430.38% to $5.2 million in 2023.
- The last three Receivables - Net figures came in at $5.2 million (Q4 2023), $5.2 million (Q3 2023), and $524000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.16 Mn |
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 5.16 Mn |
| Sep 30, 2023 | 5.16 Mn |
| Jun 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 524,000.00 |
| Sep 30, 2021 | 79,000.00 |
| Sep 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | 174,000.00 |
| Mar 31, 2020 | 174,000.00 |